How the COVID-19 Pandemic Impacted Oncological Molecular Diagnosis: A Picture from a National Reference Center for Molecular Pathology

Table 1

Comparison between discrete variables evaluated in both cohorts.

Evaluated variables	Type	2019 ()	2019 (%)	2020 ()	2020 (%)	value
Institution	PNHS type I	99	29.03%	102	35.92%	0.0153
	PNHS type II	111	32.55%	66	23.24%
	PNHS type III	91	26.69%	68	23.94%
	PL	40	11.73%	48	16.90%
Region	North	165	48.39%	129	45.42%	0.0146
	Center	39	11.44%	45	15.85%
	LTV	122	35.78%	108	38.03%
	Algarve	15	4.40%	2	0.70%
Sample	LB	36	10.56%	13	4.58%	0.0067
	TCB	305	89.44%	271	95.42%
Molecular test	NGS	164	48.09%	147	51.76%	<0.0001
	Sanger	29	8.50%	38	13.38%
	Idylla	145	42.52%	80	28.17%
	PCR-based capillary electrophoresis	2	0.59%	17	5.99%
	Digital PCR	1	0.29%	2	0.70%